Religare Enterp. Q1 FY27 Earnings Call — Analysis (NSE: RELIGARE)

RBI rejects Religare's demerger application; management to re-engage with regulator while Care Health Insurance delivers strong 37% GWP growth.

19 Aug 2026 · Analysis by Alpha Inflection

Result quality: poor — Slipped to loss. Management sentiment: optimistic.

The take

Q1FY27 Consolidated Total Income ₹2,358 Cr ( +26% YoY ) . New guidance — FY28 care health insurance combined… 100% . New story: Demerger regulatory uncertainty .

Results

Consolidated revenue ₹2,358 Cr (+26% YoY); PAT -₹46.9 Cr due to Ind AS 117 non-implementation in consolidation; Care Health standalone PBT ₹163 Cr (+60% YoY); Broking PBT ₹10 Cr (+53% YoY).

Financial highlights

Guidance

Care Health targets combined ratio of 100% within two years and intends to outpace market growth; Finvest to restart lending in 3–4 months with ₹10,000–15,000 Cr book ambition.

What management committed to

• Care Health Insurance aims to achieve a combined ratio of 100% within the next two years. — 100%, FY28
• Care Health Insurance expects its growth to continue outpacing the industry. — FY27
• Religare Finvest will commence lending business in the next three to four months [by Nov-Dec 2026]. — Q3FY27
• Care Health Insurance will maintain its solvency ratio at 1.7x or higher. — 1.7x, ongoing
• Religare Housing Finance will receive INR250 crores of additional capital [from REL] over the next few years. — INR250 crores, next few years
• Religare Finvest has ambitions to build a book size of INR10,000–15,000 crores. — INR10,000 crores - INR15,000 crores

Key themes

Demerger setback, insurance outperformance, financial services rebuild

How the narrative shifted

• Demerger regulatory uncertainty: Management frames the RBI non-approval as an engagement opportunity without disclosing reasons; no timeline, but demerger remains central to value unlocking.
• Care Health land-grab growth: Ajay Shah describes the post-GST health insurance market as a 'land grab moment' with rapid retail expansion and market share gains, driven by Tier 2/3 consumers.
• Financial services rebuild & capital deployment: New leadership hired across Finvest, Housing, and Broking; significant idle capital in Finvest (₹915 Cr net worth) to be deployed with restart in 3–4 months.
• Broking repair and model uncertainty: Broking business is in high-speed repair and investment; management unable to articulate competitive differentiation today, promises clarity in 1–2 quarters.
• Solvency and capitalization discipline at Care: Care raised capital through rights and sub-debt, aims to maintain 1.7x solvency; promoters committed to fund further growth via rights issues.
• Affordable housing structural tailwinds: Management cites favorable government initiatives, robust retail credit story, and growing demand in affordable mortgage segment as backdrop for housing finance rebuild.

Operational commentary

• RBI communicated non-approval of demerger scheme; management engaging with regulator, no specific reason disclosed, no timeline for resolution.
• Care Health Insurance recorded 37% GWP growth, outgrowing industry; retail market share expanded to 12.6% of industry and 24% among SAHIs; retail new business grew >50%.
• Care raised ₹150 Cr equity via rights issue in Q1FY27 and ₹200 Cr sub-debt in August 2026; management committed to maintain solvency at 1.7x.
• Religare Finvest appointed new CEO (Srinivasan Karthik from HDB) and is rebuilding technology stack; business restart targeted in 3–4 months; sits on ₹915 Cr net worth and ₹600+ Cr cash.
• Religare Housing Finance appointed new MD & CEO (Pavan Gupta, ex-Muthoot Housing) and CFO (Pankaj Rathi, ex-Grihum); focus on self-employed/informal segments in semi-urban markets; current 15 branches, 2,800 customers, AUM ₹247 Cr.
• Religare Broking in ‘repair and investment’ mode under new leadership; building next-gen platform, scaling margin funding and third-party product distribution; client debit book grew 78%.
• Care Health digital maturity: 99.9% policies issued digitally, 85% cashless claims processed within 30 minutes, 13.2 mn app installs.

Analyst Q&A

• Q. Reason for RBI declining the demerger scheme, and does the company have a Plan B?

  The RBI letter gave no specific reasoning; we are engaging with the regulator. Currently we are not looking at alternatives; priority is to satisfy the regulator.

• Q. Explaining high combined ratio and Insurance Service Result loss vs. calculation

  Q1 is skewed by corporate wellness book with upfront claims; combined ratio will come down during the year; CISR includes non-attributable expenses not in Insurance Service Result.

• Q. Growth drivers for 37% premium growth – split between fresh, portability, and ticket size?

  Fresh business growing fastest; number of consumers growing faster than average ticket size, driven by Tier 2/3 geographies; port-in share has come down drastically.

• Q. What will be Religare Broking's model to compete in a cluttered market?

  We are repairing the business; clear direction on the model will be clear in one to two quarters, and we will report back then.

• Q. What is the plan if the demerger does not happen – any option B?

  Any value unlock requires RBI approval; we are focused on engaging the regulator and will explore options after that. No parallel plan at this stage.

View source

Research and educational content only. Not investment advice.